162 related articles for article (PubMed ID: 2992298)
1. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
Haskett RF
Am J Psychiatry; 1985 Aug; 142(8):911-6. PubMed ID: 2992298
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
Starkman MN; Schteingart DE
Arch Intern Med; 1981 Feb; 141(2):215-9. PubMed ID: 6257194
[TBL] [Abstract][Full Text] [Related]
3. Phenomenology and family history of affective disorder in Cushing's disease.
Hudson JI; Hudson MS; Griffing GT; Melby JC; Pope HG
Am J Psychiatry; 1987 Jul; 144(7):951-3. PubMed ID: 3605410
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
Krystal A; Krishnan KR; Raitiere M; Poland R; Ritchie JC; Dunnick NR; Hanada K; Nemeroff CB
J Neuropsychiatry Clin Neurosci; 1990; 2(1):34-43. PubMed ID: 1967010
[TBL] [Abstract][Full Text] [Related]
5. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
Starkman MN; Schteingart DE; Schork MA
Psychosom Med; 1981 Feb; 43(1):3-18. PubMed ID: 6259680
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of psychiatric and psychological aspects of Cushing's syndrome.
Kelly WF; Kelly MJ; Faragher B
Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
8. Mania in Cushing's syndrome: case report.
Reed K; Watkins M; Dobson H
J Clin Psychiatry; 1983 Dec; 44(12):460-2. PubMed ID: 6317660
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric phenomenology in Cushing's disease.
Loosen PT; Chambliss B; DeBold CR; Shelton R; Orth DN
Pharmacopsychiatry; 1992 Jul; 25(4):192-8. PubMed ID: 1528959
[TBL] [Abstract][Full Text] [Related]
10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric disorders associated with Cushing's syndrome.
Bratek A; Koźmin-Burzyńska A; Górniak E; Krysta K
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S339-43. PubMed ID: 26417792
[TBL] [Abstract][Full Text] [Related]
12. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
[TBL] [Abstract][Full Text] [Related]
14. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
16. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
18. Affective disorders and endocrine disease. New insights from psychosomatic studies.
Fava GA
Psychosomatics; 1994; 35(4):341-53. PubMed ID: 8084985
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
20. Depression and Cushing's syndrome.
Lancet; 1986 Sep; 2(8506):550-1. PubMed ID: 2875285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
